Pillar Therapeutics
Boston, US · Founded 2026 · Delaware corporation
Founders & leadership
CG
COSMAS GIALLOURAKISVNamed on SEC filing
AC
AMANDA CREEDONNamed on SEC filing
Board
TC
TESS CAMERONBoard director
JH
JENNA HEBERTBoard director
Reported raises · per SEC filings
Form D private placements$14M disclosed across 1 round · 2026
▶$14MraisedMay 2026 · 2 investors · BiotechnologyRule 506(b)
▶$14MraisedMay 2026 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JENNA HEBERTDirector
- COSMAS GIALLOURAKISVExecutive Officer, Director, Promoter
- TESS CAMERONDirector
- AMANDA CREEDONExecutive Officer
- Offering amount
- $25M
- Amount sold
- $14M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Pillar Therapeutics raised?
- Pillar Therapeutics has disclosed $14M raised across 1 round.
- Where is Pillar Therapeutics headquartered?
- Pillar Therapeutics is headquartered in Boston, US.